Buy Mphasis; target of Rs 390: Dolat Capital

Published on Fri, Dec 02, 2011 at 12:25 |  Source : Moneycontrol.com

Updated at Fri, Dec 02, 2011 at 12:51  

13082 Investors following MphasiS. Share this News with them.
0
0
Share on Tumblr
Buy Mphasis; target of Rs 390: Dolat Capital

RELATED NEWS

ALSO READ

Dolat Capital is bullish on Mphasis and has recommended buy rating on the stock with a target of Rs 390 in its December 1, 2011 research report.

"Mphasis declared its Q4FY11 results, with a revenue decline of 3.8% QoQ at USD 276mn - 4% below our estimates. Growth in rupee terms was 2% at ` 13.1bn. the growth was largely driven by momentum in the direct channel business growth and consolidation of Wyde financials for two months. Wyde contributed about ` 199mn for the two months of consolidation. Revenue from HP portfolio was down by 4.9% QoQ despite the strong growth in the non-enterprise portion that grew by 14.2% sequentially at Rs 580mn. The management expect revenue from the HP non-enterprise segment to clock USD 100mn mark in FY12 (FY11 - USD35mn). Its master service agreement will come for renewal in late FY12 and thus we don't expect any significant downtick in portfolio pricing. It added 25 new clients - 17 in the direct channels and is witnessing strong business traction in the Insurance and BCM segment."

"The company has about 1,300 open positions to be added in the App/ITO business segment. But the BPO segment may see some more rationalization in the quarter. Adjusted margin improved by 200bps during the quarter and the management expect to maintain the operating margins at about 15% in FY12. PAT declined 6% QoQ at ` 1.83bn due to higher effective tax rate of 24.1% as against 22% in the previous quarter. We have cut our FY12 EPS estimate by 9% in view of subdued outlook on HP's enterprise business and weak margin management. At CMP of ` 315, the stock is trading at an attractive valuation of 7x of its FY13 April earnings however the concern pertaining to business from HP and pricing/margin slippage would remain an overhang"

"We believe the results were disappointing as the company continues to report one time items quarter after quarter. Though the valuations are quite compelling at 7x 1-yr fwd but however the low offtake from HP and weak sentiment in parent's earning commentary remains an overhang. We maintain our Buy recommendation but with a cautious stance," says Dolat Capital research report. 

Public holding more than 90% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

  

Trending News

Business News

Google ChromeOS goes big with Chromebox, new Chromebook
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

Coal Ministry Lions Share Of 16 Of 49 Coal Blocks For Power Sector

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!